Berry Genomics Co.,Ltd (000710.SZ)
CNY 10.25
(-2.38%)
CNY 10.25
(-2.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.15 Billion | 1.36 Billion | 1.42 Billion | 1.54 Billion | 1.61 Billion | 1.43 Billion |
| Cost of Revenue | 668.25 Million | 783.64 Million | 785.97 Million | 729.75 Million | 628.8 Million | 601.28 Million |
| Gross Profit | 483.15 Million | 584.36 Million | 636.2 Million | 810.62 Million | 988.83 Million | 838.5 Million |
| Operating Expenses | 933.9 Million | 607.6 Million | 620.05 Million | 553.7 Million | 536.59 Million | 481.7 Million |
| Selling, General and Administrative Expenses | 319.48 Million | 327.2 Million | 357.3 Million | 325.8 Million | 329.01 Million | 304.33 Million |
| Research and Development Expenses | 110.01 Million | 106.73 Million | 128.22 Million | 125.79 Million | 119.5 Million | 91.27 Million |
| Other Expenses | 256.57 Million | 173.66 Million | 134.52 Million | 102.1 Million | 88.07 Million | 86.09 Million |
| Cost and Expenses | 1.6 Billion | 1.39 Billion | 1.4 Billion | 1.28 Billion | 1.16 Billion | 1.08 Billion |
| Operating Income | -198.83 Million | -23.24 Million | -38.82 Million | 245.16 Million | 450.18 Million | 305.05 Million |
| Interest Expense | 16.62 Million | 17.63 Million | 20.29 Million | 15.33 Million | 86.46 Thousand | 879.62 Thousand |
| Income Tax Expense | -28.15 Million | -31 Million | -10.51 Million | 39.65 Million | 58.53 Million | 51.17 Million |
| Earnings before Tax | -453.42 Million | -283.25 Million | -120.38 Million | 245.34 Million | 445.66 Million | 310.94 Million |
| Net Income | -427.19 Million | -252.24 Million | -109.86 Million | 210.66 Million | 390.61 Million | 268.09 Million |
| Earnings Per Share Basic | -1.21 | -0.71 | -0.31 | 0.60 | 1.10 | 0.76 |
| Earnings Per Share Diluted | -1.21 | -0.71 | -0.31 | 0.60 | 1.10 | 0.76 |
| Weighted Average Shares Outstanding | 353.05 Million | 353.52 Million | 353.52 Million | 350.69 Million | 354.32 Million | 352.75 Million |
| Weighted Average Shares Outstanding (Diluted) | 353.05 Million | 353.52 Million | 353.52 Million | 350.69 Million | 354.32 Million | 352.75 Million |
| Gross Margin | 0.42 | 0.43 | 0.45 | 0.53 | 0.61 | 0.58 |
| EBIT Margin | -0.23 | -0.05 | 0.05 | 0.24 | 0.34 | 0.27 |
| Profit Margin | -0.37 | -0.18 | -0.08 | 0.14 | 0.24 | 0.19 |
| EBITDA | -268.33 Million | -62.24 Million | 67.57 Million | 337.58 Million | 511.98 Million | 391.75 Million |
| Earnings Before Tax Margin | -0.17 | -0.02 | -0.03 | 0.16 | 0.28 | 0.21 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 270.88 Million | 269.21 Million | 277.53 Million | 285.81 Million | 1.15 Billion | 304.9 Million |
| Cost of Revenue | 142.55 Million | 154.34 Million | 125.62 Million | 162.18 Million | 636.22 Million | 156.67 Million |
| Gross Profit | 128.33 Million | 114.86 Million | 151.9 Million | 123.62 Million | 515.19 Million | 148.23 Million |
| Operating Expenses | 114.64 Million | 105.83 Million | 130.76 Million | 122.26 Million | 545.15 Million | 148.32 Million |
| Selling, General and Administrative Expenses | 210.95 Million | 88.44 Million | 110.06 Million | -29.02 Million | - | 185.48 Million |
| Research and Development Expenses | 18.68 Million | 17.38 Million | 20.69 Million | 37.68 Million | - | 24.81 Million |
| Other Expenses | -114.99 Million | -223.33 Thousand | -647.2 Thousand | -1.84 Million | -2.68 Million | 13.3 Million |
| Cost and Expenses | 257.19 Million | 260.17 Million | 256.38 Million | 284.45 Million | 1.18 Billion | 304.99 Million |
| Operating Income | 5.65 Million | 9.03 Million | 21.14 Million | -329.37 Million | -450.74 Million | -31.16 Million |
| Interest Expense | - | 3.43 Million | 2.95 Million | - | 16.35 Million | 3.37 Million |
| Income Tax Expense | 3.6 Million | 4.53 Million | 4.21 Million | -39.08 Million | -28.15 Million | 7.9 Million |
| Earnings before Tax | 5.47 Million | 12.22 Million | 13.63 Million | -331.21 Million | -453.42 Million | -31.44 Million |
| Net Income | 1.12 Million | 1.02 Million | 8.23 Million | -292.23 Million | -427.19 Million | -39.84 Million |
| Earnings Per Share Basic | 0.00 | 0.00 | 0.02 | -0.83 | - | -0.11 |
| Earnings Per Share Diluted | 0.00 | 0.00 | 0.02 | -0.83 | - | -0.11 |
| Weighted Average Shares Outstanding | 353.52 Million | 353.52 Million | 353.52 Million | 353.28 Million | 353.05 Million | 353.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 353.52 Million | 353.52 Million | 353.52 Million | 353.28 Million | 353.05 Million | 353.52 Million |
| Gross Margin | 0.47 | 0.43 | 0.55 | 0.43 | 0.45 | 0.49 |
| EBIT Margin | 0.13 | 0.13 | 0.12 | -0.31 | - | 0.28 |
| Profit Margin | 0.00 | 0.00 | 0.03 | -1.02 | -0.37 | -0.13 |
| EBITDA | 35.29 Million | 36.01 Million | 32.12 Million | -87.91 Million | - | 84.93 Million |
| Earnings Before Tax Margin | 0.02 | 0.03 | 0.08 | -1.15 | -0.39 | -0.10 |
RVU
FCX
603083
SPC
COX
2436